Company intelligence / Profile preview

Hill Dermaceuticals, Inc.

Sanford, Florida, United Stateshillderm.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hill Dermaceuticals develops and manufactures prescription dermatology products for children and adults. Its lead product TOLAK® has been commercialized in partnership with Pierre Fabre for actinic keratosis. The company focuses on difficult-to-treat skin diseases and maintains a portfolio of unique topical therapies.

Therapeutic areas: Dermatology
Modalities: Small molecules (topical dermatology drugs)
Industry: Biotech

Drug pipeline

1 asset

fluocinolone acetonide topical oil

Approved

Partnerships

Pierre Fabre Dermo-Cosmétique / Pierre Fabre Dermatologie – strategic commercial partnership for TOLAK® distribution/licensing in USA and internationally

Beyond the preview

Go deeper on Hill Dermaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hill Dermaceuticals, Inc..

Explore the full profile